Editorial Board Disclosure Policy
(Last updated Oct 2024)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Professor Clara Alvarez
Professor Alvarez has the following financial activities to declare: Board of Spanish Research Council, Area 18-BIO from September 2018 to February 2024. Full Professor. Principal Investigator. Centre for Research in Molecular Medicine (CIMUS) at the University of Santiago de Compostela (USC). She has had travel expenses paid to attend the European Thyroid Association Meeting 2023 to make a Summary Webinar in Spanish for the Spanish Endocrine Society. Professor Alvarez also declares the following patent: Patent number: Oficina Española de Patentes y Marcas (OEPM), Nº Publicación WO2021028610 A1. Title: “COMPUESTOS Y MÉTODOS PARA EL TRATAMIENTO DEL CÁNCER”, PCT/ES2020/070512
Professor Alvarez has the following financial activities to declare: Board of Spanish Research Council, Area 18-BIO from September 2018 to February 2024. Full Professor. Principal Investigator. Centre for Research in Molecular Medicine (CIMUS) at the University of Santiago de Compostela (USC). She has had travel expenses paid to attend the European Thyroid Association Meeting 2023 to make a Summary Webinar in Spanish for the Spanish Endocrine Society. Professor Alvarez also declares the following patent: Patent number: Oficina Española de Patentes y Marcas (OEPM), Nº Publicación WO2021028610 A1. Title: “COMPUESTOS Y MÉTODOS PARA EL TRATAMIENTO DEL CÁNCER”, PCT/ES2020/070512
Dr Charlotte Bevan
Dr Bevan has received studentships in partnership with Carrick Therapeutics.
Dr Bevan has received studentships in partnership with Carrick Therapeutics.
Dr Elizabeth Caldon
Dr Caldon had a since terminated contract research agreement in 2020 with Constellation Pharmaceuticals plus provision of drugs, and also received honoraria from Eli Lilly.
Dr Caldon had a since terminated contract research agreement in 2020 with Constellation Pharmaceuticals plus provision of drugs, and also received honoraria from Eli Lilly.
Dr Ruth Casey
Dr Casey has received honoraria from Novartis for an educational session in 2022.
Dr Casey has received honoraria from Novartis for an educational session in 2022.
Professor Justo Castaño
Dr Castaño has received travel or speaker honoraria from Ipsen, AAA/Novartis. He is a member of the ENETS Advisory Board, and ESE Publications and Communications Committee.
Dr Castaño has received travel or speaker honoraria from Ipsen, AAA/Novartis. He is a member of the ENETS Advisory Board, and ESE Publications and Communications Committee.
Dr Ben Challis
Dr Challis is an employee of AstraZenaca and holds AstraZeneca stocks and share options.
Dr Challis is an employee of AstraZenaca and holds AstraZeneca stocks and share options.
Professor Roderick Clifton-Bligh
Professor Clifton-Bligh has received speaker's bureaus from: Eisai, AMGEN. He has received Advisory Board fees from: IPSEN, AMGEN, Eisai, KIRIN. Non-financial support has been provided by Eisai for the provision of drugs for preclinical studies. He serves as Editor for Journal of the Endocrine Society and European Thyroid Journal
Professor Clifton-Bligh has received speaker's bureaus from: Eisai, AMGEN. He has received Advisory Board fees from: IPSEN, AMGEN, Eisai, KIRIN. Non-financial support has been provided by Eisai for the provision of drugs for preclinical studies. He serves as Editor for Journal of the Endocrine Society and European Thyroid Journal
Dr Scott Dehm
Dr Dehm consults for Oncternal Therapeutics and Bristol-Myers Squibb.
Dr Dehm consults for Oncternal Therapeutics and Bristol-Myers Squibb.
Professor Tobias Else
Professor Else has received grants from the NIH and Department of Defense, and acts on the Advisory board of HRA Pharma, Merck and Lantheus.
Professor Else has received grants from the NIH and Department of Defense, and acts on the Advisory board of HRA Pharma, Merck and Lantheus.
Professor Simona Glasberg
Professor Glasberg has received research grants from Medison and Novartis, and consultancy for Serb, Camurus, Triple A, Debiopharm and ITM. She has a patent pending, Hadasit Ref: 996-01 - US Patent Application No. 63/343,129 for "Combination of endocannabinoid and mTOR inhibitors in the treatment of neuroendocrine neoplasms". She is a Senior Editor for Journal of Neuroendocrinology; and Chair of the ENETS Carcinoid Heart Disease Task Force, Co-Chair of ESE Rare Disease Committee, Member of ESE Executive Committee (2019-2023), Co-Leader of the Working Group for Research Roadmap in Neuroendocrine Tumors of ESE, Member of the Israel Endocrine Society Executive Committee and a Member of ESMO Faculty.
Professor Glasberg has received research grants from Medison and Novartis, and consultancy for Serb, Camurus, Triple A, Debiopharm and ITM. She has a patent pending, Hadasit Ref: 996-01 - US Patent Application No. 63/343,129 for "Combination of endocannabinoid and mTOR inhibitors in the treatment of neuroendocrine neoplasms". She is a Senior Editor for Journal of Neuroendocrinology; and Chair of the ENETS Carcinoid Heart Disease Task Force, Co-Chair of ESE Rare Disease Committee, Member of ESE Executive Committee (2019-2023), Co-Leader of the Working Group for Research Roadmap in Neuroendocrine Tumors of ESE, Member of the Israel Endocrine Society Executive Committee and a Member of ESMO Faculty.
Professor Haggi Mazeh
Professor Mazeh serves on the Editorial Board for the following journals: World Journal of Surgery, The Oncologist, Journal of Surgical Research, Global Journal of Surgery, World Journal of Gastrointestinal Surgery, and World Journal of Gastrointestinal Endoscopy.
Professor Hannelore Heemers
Professor Heemers has received grant support from VeloSano, VeloSano8 pilot research award, the Department of Cancer Biology/Cleveland Clinic Cancer Biology MultiPI Project Development Award and the NIH/NCI. They act as a paid reviewer on the NCI study section MCT2/MCTA, reviewer and chair on review panels for Congressionally Directed Medical Research Programs and the Prostate Cancer Research Program. Dr Heemers is also the inventor on US patent application PCT/US2022/02349.
Professor Heemers has received grant support from VeloSano, VeloSano8 pilot research award, the Department of Cancer Biology/Cleveland Clinic Cancer Biology MultiPI Project Development Award and the NIH/NCI. They act as a paid reviewer on the NCI study section MCT2/MCTA, reviewer and chair on review panels for Congressionally Directed Medical Research Programs and the Prostate Cancer Research Program. Dr Heemers is also the inventor on US patent application PCT/US2022/02349.
Dr Yasuhiro Miki
Dr Miki is on the Editorial Boards for Plos One, Interenational Journal of Molecular Science and Journal of Clinical Medicine.
Dr Miki is on the Editorial Boards for Plos One, Interenational Journal of Molecular Science and Journal of Clinical Medicine.
Professor Johannes Hofland
Professor Hofland has received Advisory board fee or speaker fee from Novartis, Ipsen and Serb. He is also an Editor for Endotext.org.
Professor Hofland has received Advisory board fee or speaker fee from Novartis, Ipsen and Serb. He is also an Editor for Endotext.org.
Dr Lawrence Kirschner
Dr Kirschner has received research support from the NIH. He also serves as site PI for industry sponsored clinical trials (which may include support for resources or staff, as well as travel to investigator meetings) for the following companies: Corcept, Crinetics, CinCOR, Sparrow, Spruce and Adrenas. He has also received payment from consulting and serving on the speaker’s bureau for Corcept and holds patents on identification of PRKAR1A as the cause of Carney Complex.
Dr Kirschner has received research support from the NIH. He also serves as site PI for industry sponsored clinical trials (which may include support for resources or staff, as well as travel to investigator meetings) for the following companies: Corcept, Crinetics, CinCOR, Sparrow, Spruce and Adrenas. He has also received payment from consulting and serving on the speaker’s bureau for Corcept and holds patents on identification of PRKAR1A as the cause of Carney Complex.
Professor André Lacroix
Professor Lacroix has received Clinical and Research Fellows salary support to his institution from Pfizer, Recordati, Ipsen and Corcept.
Professor Lacroix has received Clinical and Research Fellows salary support to his institution from Pfizer, Recordati, Ipsen and Corcept.
Dr Claudio Luchini
Dr Luchini is National coordinator and PI of the following grant: PRIN 2022 (CUP: B53D23008010006) funded by Italian Ministry of University and Research. He has received consulting fees from NTP, and speaking fees from MSD and Medica srl. He acts as Associate Editor for BMC Gastroenterology and serves on the Editorial Board of the following journals: Virchows Archiv, Human Pathology, Pathology Research and Practice, and Pathologica. He is also Chair of the Educational Committee of the Pancreatobiliary Pathology Society of United States and Canadian Academy of Pathology (PBPS/USCAP).
Dr Luchini is National coordinator and PI of the following grant: PRIN 2022 (CUP: B53D23008010006) funded by Italian Ministry of University and Research. He has received consulting fees from NTP, and speaking fees from MSD and Medica srl. He acts as Associate Editor for BMC Gastroenterology and serves on the Editorial Board of the following journals: Virchows Archiv, Human Pathology, Pathology Research and Practice, and Pathologica. He is also Chair of the Educational Committee of the Pancreatobiliary Pathology Society of United States and Canadian Academy of Pathology (PBPS/USCAP).
Professor Rachel Riechelmann
Professor Riechelmann has received honoraria for lectures from Ipsen. She serves on the Editorial Boards for the following journals: ECancerMedicalScience; Therapeutical Advances in Medical Oncology; BMJ Oncology; ESMO Gastrointestinal Journal.
Professor Riechelmann has received honoraria for lectures from Ipsen. She serves on the Editorial Boards for the following journals: ECancerMedicalScience; Therapeutical Advances in Medical Oncology; BMJ Oncology; ESMO Gastrointestinal Journal.
Dr Cristina Ronchi
Dr Ronchi has received research grants from HRA Pharma.
Dr Ronchi has received research grants from HRA Pharma.
Professor Shigehira Saji
Professor Shigehira Saji consults for Astra Zeneca, Chugai, Eli Lilly, Kyowa Kirin, MSD, Ono and Pfizer. They also carry out contracted research for Astra Zeneca, Chugai, Daiichi Sankyo, MSD and Taiho, and have received payment for lecturing at Astra Zeneca, Chugai, Eli Lilly, Kyowa Kirin, MSD, Ono and Pfizer.
Professor Shigehira Saji consults for Astra Zeneca, Chugai, Eli Lilly, Kyowa Kirin, MSD, Ono and Pfizer. They also carry out contracted research for Astra Zeneca, Chugai, Daiichi Sankyo, MSD and Taiho, and have received payment for lecturing at Astra Zeneca, Chugai, Eli Lilly, Kyowa Kirin, MSD, Ono and Pfizer.
Dr Ishita B Sen
Dr Sen has received fee for consulting lectures by Perspective therapeutics, USA.
Dr Sen has received fee for consulting lectures by Perspective therapeutics, USA.
Dr Renea Taylor
Dr Taylor is on the Editorial Board of Endocrine Connections.
Dr Taylor is on the Editorial Board of Endocrine Connections.
Professor Marily Theodoropoulou
Professor Theodoropoulou Therodoropoloulou has received grants from the German Research Foundation (DFG) and Crinetics Pharmaceuticals Inc.
Professor Theodoropoulou Therodoropoloulou has received grants from the German Research Foundation (DFG) and Crinetics Pharmaceuticals Inc.
Dr Nicole Unger
Dr Unger is on the advisory board for Merck Serono. She also received speaker fees from Ipsen, Recordati Rare Diseases, Merck Serono and HRA Pharma.
Dr Unger is on the advisory board for Merck Serono. She also received speaker fees from Ipsen, Recordati Rare Diseases, Merck Serono and HRA Pharma.
Dr Maria Chiara Zatelli
Dr Zatelli has received honoraria from Sandoz and is an Associate Editor for Endocrine.
Dr Zatelli has received honoraria from Sandoz and is an Associate Editor for Endocrine.
The following editors reported no competing interests:
- Dr Kate Lines
- Professor Patrick Petrossians
- Professor Riccarda Granata
- Dr Gail Prins
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).
